NALP4 Polyclonal Antibody, FITC Conjugated
Product Specifications
Synonyms
Nucleotide binding oligomerization domain, leucine rich repeat and pyrin domain containing 4; Cancer/testis antigen 58; CLR19.5; CT58; NACHT, leucine rich repeat and PYD containing 4; NACHT, LRR and PYD containing protein 4; NACHT, LRR and PYD domains-containing protein 4; NALP4_HUMAN; NLR family, pyrin domain containing 4; NLRP4; NALP4G; PAAD and NACHT containing protein 2; PAAD and NACHT-containing protein 2; PAN2; PYPAF4; PYRIN and NACHT-containing protein 2; PYRIN containing APAF1 like protein 4; PYRIN-containing APAF1-like protein 4; Ribonuclease inhibitor 2; RNH2.
Gene ID
147945
Swiss Prot
Q96MN2
Cellular Locus
Cytoplasm, Secreted, Extracellular matrix
Host
Rabbit
Cross Reactivity
Human
Target
NALP4
Clonality
Polyclonal
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human NALP4
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
1mg/ml
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
147945
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
